Medifast, Inc. announces quarterly dividend
BALTIMORE, June 3, 2021 / PRNewswire / – Medifast, Inc. (NYSE: MED), the global company behind one of the fastest growing health and wellness communities, OPTAVIA®, today announced that its board of directors has declared a $ 1.42 quarterly cash dividend to its shareholders. The quarterly cash dividend of $ 1.42 per share is payable on August 6, 2021 to shareholders of record at the close of business on June 22, 2021.
Medifast plans to maintain a dividend payment program on a quarterly basis. However, the declaration of dividends in the future is subject to the discretion of the Board of Directors of the Company, which will from time to time evaluate the Company’s dividend program based on such factors as it deems relevant.
Medifast (NYSE: MED) is the global company behind one of the fastest growing health and wellness communities, OPTAVIA®, which offers scientifically developed products, clinically proven plans, and the support of coaches and a community to help clients achieve lifelong transformation, one healthy habit at a time®. Drawing on nearly 40 years of experience, Medifast has redefined direct selling by combining the best aspects of the model. Its community of thousands of independents OPTAVIA Coaches teach clients how to develop healthy and holistic habits through the exclusive Habits of Health® transformation system. Medifast is listed on the New York Stock Exchange and ranked second on FORTUNE’s 100 Fastest Growing Companies list of 2020. The company was also named to Forbes’ list of America’s 100 Most Trusted Companies in 2017. For more information, visit www.MedifastInc. com or www.OPTAVIA.com.
Note: This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements can generally be identified by the use of phrases or terminology such as “intend”, “anticipate”, “expect” or other similar words or the negative of this terminology. Likewise, the descriptions of Medifast’s objectives, strategies, plans, goals or targets contained herein are also considered to be forward-looking statements. These statements are based on the current expectations of Medifast management and are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, the risks associated with Medifast’s direct-to-consumer business model, the impact of rapid growth on Medifast’s systems, disruptions in Medifast’s supply chain, inability of Medifast to continue to develop new services and products, the effectiveness of advertising and marketing programs, including the use of social media by OPTAVIA Coaches, Medifast’s inability to maintain and develop the independent coach network OPTAVIA Coaches, the departure of one or more key personnel, Medifast’s inability to protect itself against online security risks, to protect its brand, to protect itself against product liability claims, expected growth of Medifast in national and international markets, negative publicity associated with the products or activities of Medifast units, inability of Medifast to continue declaring dividends, fluctuations in Medifast’s stock price, impact of the COVID-19 pandemic on Medifast results, severity, duration and ultimate impact of COVID-19 on people and economies, increased competition, litigation, consequences of other geopolitical events, natural disasters, acts of war or climate change, activist investors, regulatory changes, market conditions and the resulting impact on consumer spending , a failure of internal control over financial reporting and any limitations imposed by Medifast’s debt agreements. While Medifast believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always carefully consider all risk factors and any other caveats when evaluating each statement. forward-looking statements in this press release, as well as those set out in its annual report on Form 10-K for the year ended December 31, 2020, its quarterly report on Form 10-Q for the quarter ended March 31, 2021, and other documents filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All forward-looking statements contained in this document speak only as of the date of this press release.
SOURCE Medifast, Inc.